Economic burden of adverse events associated with first line Metastatic Renal Cell Carcinoma (MRCC) treatment in public and Private Brazilian Perspective
May 1, 2015, 00:00
10.1016/j.jval.2015.03.1464
https://www.valueinhealthjournal.com/article/S1098-3015(15)01521-1/fulltext
Title :
Economic burden of adverse events associated with first line Metastatic Renal Cell Carcinoma (MRCC) treatment in public and Private Brazilian Perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)01521-1&doi=10.1016/j.jval.2015.03.1464
First page :
A251
Section Title :
Health Services
Open access? :
No
Section Order :
930